| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |